𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cell-mediated tumour immunity in patients with transitional cell carcinoma of the urinary bladder

✍ Scribed by J. Bubeník

Publisher
Springer Netherlands
Year
1975
Tongue
English
Weight
399 KB
Volume
7
Category
Article
ISSN
0301-1623

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Metachronous bladder tumors in patients
Metachronous bladder tumors in patients with upper urinary tract transitional cell carcinoma
✍ Eliahu Mukamel; Dan Simon; Ciro Servadio; Myriam Konichezky; Herzlia Hadar; Abra 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 326 KB 👁 1 views

Sixty-nine patients who underwent nephroureterectomy for upper urinary tract transitional cell carcinoma were included in the study. The following data were collected for each patient: grade and stage of renalhreteral tumor, tumor location, timing of tumor appearance and recurrence in the bladder, g

Coexisting leiomyosarcoma and transition
Coexisting leiomyosarcoma and transitional cell carcinoma of the urinary bladder
✍ Dr. Karl T. K. Chen 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 498 KB 👁 2 views

A rare case of coexisting sarcoma and carcinoma of the urinary bladder is reported and the literature is reviewed. Because of the differences in the histogenesis and prognosis, such cases should be differentiated from cases of carcinosarcoma of the urinary bladder.

Cellular immunity to transitional cell c
Cellular immunity to transitional cell carcinoma of the urinary bladder. III. Effects of hydrostatic pressure therapy
✍ Carol O'Toole; K. Helmstein; P. Perlmann; G. Moberger 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 French ⚖ 820 KB

## Abstract The effects of hydrostatic pressure therapy on in vitro cellular cytotoxicity responses have been studied in 19 patients with transitional cell carcinoma of the bladder (TCC). Cytotoxicity was quantitated against allogeneic targets in a microplate assay or by ^51^chromium isotope releas